Lataa...
A comparison of the available phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction: a focus on avanafil
BACKGROUND: Numerous pathways can lead to erectile dysfunction (ED) in patients, with some patients having multiple causes. Regardless of the etiology, ED has been successfully treated in many patients with the advent of oral phosphodiesterase-5 inhibitors (PDE5Is). With the release of avanafil, the...
Tallennettuna:
| Julkaisussa: | Patient Prefer Adherence |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4542406/ https://ncbi.nlm.nih.gov/pubmed/26316720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S56002 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|